GEHC Stock Overview
Engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
GE HealthCare Technologies Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$84.76 |
| 52 Week High | US$94.55 |
| 52 Week Low | US$71.31 |
| Beta | 1.3 |
| 1 Month Change | 2.43% |
| 3 Month Change | -6.89% |
| 1 Year Change | 11.28% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 41.27% |
Recent News & Updates
An Intrinsic Calculation For GE HealthCare Technologies Inc. (NASDAQ:GEHC) Suggests It's 37% Undervalued
Jan 03
2025 Could Be GE HealthCare's Year With Emphasis On Efficiency And AI Broadens
Dec 19With GE HealthCare Technologies Inc. (NASDAQ:GEHC) It Looks Like You'll Get What You Pay For
Dec 16GE HealthCare: Growth Acceleration In 2025 Can Drive Stock Higher
Dec 06Recent updates
An Intrinsic Calculation For GE HealthCare Technologies Inc. (NASDAQ:GEHC) Suggests It's 37% Undervalued
Jan 032025 Could Be GE HealthCare's Year With Emphasis On Efficiency And AI Broadens
Dec 19With GE HealthCare Technologies Inc. (NASDAQ:GEHC) It Looks Like You'll Get What You Pay For
Dec 16GE HealthCare: Growth Acceleration In 2025 Can Drive Stock Higher
Dec 06From Spin-Off To Standout: GE HealthCare Is Pretty Impressive
Oct 30GE HealthCare: The Image Of More Upside Is Very Real
Sep 18Are Investors Undervaluing GE HealthCare Technologies Inc. (NASDAQ:GEHC) By 28%?
Sep 05GE HealthCare Q2 Earnings Recap (Rating Downgrade)
Aug 06GE HealthCare: Near-Term Risks, But Some Interesting Longer-Term Opportunities
Jul 07Is GE HealthCare Technologies (NASDAQ:GEHC) A Risky Investment?
May 21GE HealthCare: Too Soon To Buy After A Mixed Q1 (Rating Downgrade)
May 02GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price
Apr 25GE Vernova: An Interesting Stalwart To Ride The Energy Transition
Apr 02GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive
Mar 25GE HealthCare Technologies' Roar Higher Isn't Over Yet
Mar 09Shareholder Returns
| GEHC | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 5.3% | 2.0% | -0.5% |
| 1Y | 11.3% | 9.8% | 23.2% |
Return vs Industry: GEHC exceeded the US Medical Equipment industry which returned 9.8% over the past year.
Return vs Market: GEHC underperformed the US Market which returned 23.2% over the past year.
Price Volatility
| GEHC volatility | |
|---|---|
| GEHC Average Weekly Movement | 3.1% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 18.6% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: GEHC has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: GEHC's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2022 | 51,000 | Pete Arduini | www.gehealthcare.com |
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women’s health products.
GE HealthCare Technologies Inc. Fundamentals Summary
| GEHC fundamental statistics | |
|---|---|
| Market cap | US$39.41b |
| Earnings (TTM) | US$1.68b |
| Revenue (TTM) | US$19.56b |
23.1x
P/E Ratio2.0x
P/S RatioIs GEHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GEHC income statement (TTM) | |
|---|---|
| Revenue | US$19.56b |
| Cost of Revenue | US$11.47b |
| Gross Profit | US$8.09b |
| Other Expenses | US$6.41b |
| Earnings | US$1.68b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 13, 2025
| Earnings per share (EPS) | 3.67 |
| Gross Margin | 41.34% |
| Net Profit Margin | 8.56% |
| Debt/Equity Ratio | 121.2% |
How did GEHC perform over the long term?
See historical performance and comparisonDividends
0.2%
Current Dividend Yield3%
Payout RatioDoes GEHC pay a reliable dividends?
See GEHC dividend history and benchmarks| GE HealthCare Technologies dividend dates | |
|---|---|
| Ex Dividend Date | Jan 14 2025 |
| Dividend Pay Date | Feb 14 2025 |
| Days until Ex dividend | 3 days |
| Days until Dividend pay date | 34 days |
Does GEHC pay a reliable dividends?
See GEHC dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 23:16 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
GE HealthCare Technologies Inc. is covered by 27 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Navann Ty Dietschi | BNP Paribas Exane |
| Craig Bijou | BofA Global Research |
| Michael Gorman | BTIG |